document.write("
"); document.write("
Ovsepian,\ S.V.\ ; O’Leary,\ V.B.*
"); document.write("
Can arginase inhibitors be the answer to therapeutic challenges in Alzheimer\'s disease?
"); document.write("
Neurotherapeutics 15, 1032-1035 (2018)
"); document.write("
"); document.write("
"); document.write("
O’Leary,\ V.B.*\ ; O’Connell,\ M.*\ ; Antyborzec,\ I.*\ ; Ntziachristos,\ V.\ ; Oliver Dolly,\ J.*\ ; Ovsepian,\ S.V.
"); document.write("
Alleviation of trigeminal nociception using p75 neurotrophin receptor targeted lentiviral interference therapy.
"); document.write("
Neurotherapeutics 15, 489-499 (2018)
"); document.write("
"); document.write("
"); document.write("
Antyborzec,\ I.*\ ; O\'Leary,\ V.B.\ ; Dolly,\ J.O.*\ ; Ovsepian,\ S.V.
"); document.write("
Low-affinity neurotrophin receptor p75 promotes the transduction of targeted lentiviral vectors to cholinergic neurons of rat basal forebrain.
"); document.write("
Neurotherapeutics 13, 859-870 (2016)
"); document.write("
"); document.write("
"); document.write("
Zach,\ N.*\ ; Ennist,\ D.L.*\ ; Taylor,\ A.A.*\ ; Alon,\ H.*\ ; Sherman,\ A.V.*\ ; Küffner,\ R.\ ; Walker,\ J.*\ ; Sinani,\ E.*\ ; Katsovskiy,\ I.*\ ; Cudkowicz,\ M.E.*\ ; Leitner,\ M.L.*
"); document.write("
Being PRO-ACTive: What can a clinical trial database reveal about ALS?
"); document.write("
Neurotherapeutics 12, 417-423 (2015)
"); document.write("
");